Status:
COMPLETED
A Trial to Compare the PK and PD of Insulin Lispro Administered Into Different Tissues in Subjects With Diabetes Mellitus Type 1
Lead Sponsor:
Profil Institut für Stoffwechselforschung GmbH
Conditions:
Diabetes Mellitus
Eligibility:
All Genders
18-64 years
Phase:
PHASE2
Brief Summary
The aim of this trial is to compare the pharmacokinetics and pharmacodynamics of insulin lispro injection into either lipohypertrophic lesions or normal tissue, utilizing both state-of-the-art euglyca...
Eligibility Criteria
Inclusion
- AUCINS.0-4h and AUCGIR.0-4h during treatment period 1
Exclusion
- AUCINS.0-4h and AUCBG.0-4h during treatment period 2, intra-subject variability of AUCINS.0-4h and AUCGIR.0-4h during treatment period 1
Key Trial Info
Start Date :
September 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2014
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT02221323
Start Date
September 1 2014
End Date
November 1 2014
Last Update
December 30 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Profil Institut für Stoffwechselforschung GmbH
Neuss, North Rhine-Westphalia, Germany, 41460